Clinical Trials
8 trialsNCT03252808 2024-12-09
Phase I Study of TBI-1401(HF10) Plus Chemotherapy in Patients with Unresectable Pancreatic Cancer.
Takara Bio Inc.
Phase 1 Active not recruiting
NCT00429858 2020-09-18
Gemcitabine and S-1 for Locally Advanced Unresectable or Metastatic Pancreatic Cancer
University of California, San Francisco
Phase 2 Terminated
NCT01430052 2017-11-21
Chemoradiotherapy With Gemcitabine/S-1 vs Gemcitabine/S-1 for Locally Advanced Pancreatic Cancer
Osaka Medical Center for Cancer and Cardiovascular Diseases
Phase 2 Completed
NCT01693419 2017-08-23
S-1, Gemcitabine and Erlotinib for Advanced Pancreatic Cancer
Hallym University Medical Center
Phase 2 Completed
NCT02754180 2016-04-28
Adjuvant Gemcitabine Versus Gemcitabine With Chemoradiation in Pancreatic Adenocarcinoma With R1 Resection and/or Positive Lymph Nodes
Peking Union Medical College Hospital
Phase 2 Unknown
NCT00498225 2012-11-02
GEST
Taiho Pharmaceutical Co., Ltd.
Phase 3 Completed
NCT00514163 2011-06-28
GEM vs GEM+TS-1 for Advanced Pancreatic Cancer
Japan Clinical Cancer Research Organization
Phase 2 Completed
NCT00436423 2007-11-01
A Phase â…¡ Study of Gemcitabine Combination With TS-1 in Patient With Advanced or Recurred Pancreatic Cancer
Korea University Anam Hospital
Phase 2 Completed